Starbucks Doubled EPS While Revenue Slipped 1.5%

The quarter produced a clear divergence between sales and earnings. Revenue was $9.32 billion, down from $9.46 billion in Q3 FY2025, a decline of 1.5%. Because no earnings release or management guidance was supplied, the year-ago quarter is the required reference. Revenue therefore missed that reference even as the income statement below the top line improved materially.

Pre-tax margin was 10.5%, compared with 9.9% a year earlier and 8.7% in Q2 FY2026. That represents 60 basis points of year-over-year expansion and 180 basis points of sequential improvement. It was also the strongest quarterly margin since the 11.9% recorded in Q1 FY2025. The supplied presentation treats the operating-margin column as pre-tax margin, so it should not be compared with a conventional restaurant gross-margin measure. Gross margin itself was not disclosed.

EPS increased to $0.91 from $0.49 a year earlier and $0.45 in the immediately preceding quarter. The year-over-year increase was 85.7%, far exceeding the modest margin expansion. The Starbucks Q3 FY2026 Form 10-Q data show $1.05 billion of net income against $980.4 million of operating income. The supplied extract does not explain that relationship, so it would be premature to assume that every component of the EPS increase represents recurring operating progress.

The quarterly table reports $1.35 billion of free cash flow versus $0.43 billion a year ago. That is a mechanical improvement, but free cash flow is designated as non-meaningful for this presentation and is not used in the valuation. The more relevant capital change was net debt, which declined to $9.83 billion from $13.15 billion a year earlier and $13.55 billion in Q2 FY2026. The latest point values show $13.28 billion of debt and $3.45 billion of cash.

The resulting report card is therefore better than the revenue line alone suggests. Sales contracted, but pre-tax margin, EPS and the balance-sheet position all improved. With no press release text, management guidance or operational bridge supplied, the quarter establishes that profitability improved but not precisely why.

The central question is whether Starbucks is beginning a durable earnings recovery or merely benefiting from a favorable quarter below the revenue line. Q3 provides evidence for the former, but not enough to settle the issue. A 10.5% pre-tax margin is meaningfully better than the 6.9% reported in Q2 FY2025 and the 2.9% recorded in Q4 FY2025. It nevertheless remains below the 14.4% to 18.2% range reported across the five quarters ending Q4 FY2024.

The absence of revenue growth makes that distinction important. Margin recovery achieved while sales decline can reflect cost discipline, mix or temporary items, but it does not by itself demonstrate stronger customer demand. The supplied filing extract does not disclose comparable sales, transaction counts, pricing, store growth or geography. Until revenue and margin improve together, the evidence supports stabilization rather than a completed turnaround.

EPS offers the most bullish signal. At $0.91, quarterly earnings nearly returned to the $0.93 reported in Q3 FY2024 and exceeded every quarter since then. Yet trailing EPS remains only $1.74, placing the shares at 57.0x earnings at the supplied $99.22 price. That multiple leaves limited room for a recovery that stalls or takes longer than expected.

Capital risk improved but did not disappear. Net debt declined by $3.32 billion year over year, which strengthens the financial position. At the same time, book equity was negative $7.67 billion, making conventional return-on-invested-capital calculations unreliable. The appropriate conclusion is that Q3 reduced near-term balance-sheet concern without making leverage irrelevant.

With no prior SageNoodle coverage, there is no existing fair value to carry forward or revise. We establish a provisional base-case value of $85 per share using a normalized P/E framework. Free-cash-flow yield, ROIC and EV/EBITDA are not used because they are either designated as non-meaningful or not disclosed in the supplied data.

The bear case assumes normalized EPS of $2.25 and a 20.0x multiple, producing $45 per share. This case reflects weak revenue, only partial margin recovery and a valuation reset as the market stops capitalizing the business as a premium recovery story. The base case assumes normalized EPS of $3.40 and a 25.0x multiple, producing $85. That EPS level is an explicit assumption rather than company guidance; it represents a substantial recovery from trailing EPS of $1.74 but remains close to historical annual EPS of $3.31 in FY2024 and $3.58 in FY2023.

The bull case assumes normalized EPS of $4.00 and a 30.0x multiple, producing $120 per share. It requires Q3's margin progress to persist, revenue growth to resume and the market to retain a premium multiple. We assign probabilities of 25% to the bear case, 50% to the base case and 25% to the bull case. The snapshot uses the base-case value, as required, rather than the probability-weighted result.

At $99.22, the shares trade 14.3% above the $85 base value. Because fair value is 85.7% of the market price, the stock falls just inside the Fairly Valued band under the stated verdict rule; a ratio of 85.0% or less would be Overvalued. That narrow margin reinforces the main conclusion: Q3 improved the operating evidence, but the current quotation already reflects much of the recovery.

The bearish interpretation would be wrong if Q3 marks the start of a faster normalization. If revenue returns to growth while pre-tax margin continues moving toward the mid-teens, normalized EPS could approach or exceed the $4.00 bull-case assumption. The sharp sequential rise in EPS and lower net debt provide an early foundation for that outcome, though one quarter is insufficient confirmation.

The constructive interpretation would be wrong if the EPS improvement came primarily from items that do not recur. Net income exceeded operating income in the supplied Q3 point values, and no earnings release was available to explain the difference. A reversal in below-the-line benefits could make $0.91 a poor run-rate indicator even if pre-tax margin remains near 10.5%.

Revenue is the most direct operational test. Another period of contraction would suggest that cost actions are carrying the recovery while demand remains soft. That could limit the duration of margin gains and pressure the premium valuation. Conversely, positive sales growth accompanied by stable or rising margin would materially strengthen the thesis.

Finally, leverage and negative book equity constrain the downside case. Net debt improved, but debt remained $13.28 billion. If earnings weaken again or capital requirements rise, the balance sheet could reduce strategic flexibility. The next filing needs to confirm that margin improvement, EPS quality and lower net debt can coexist with renewed top-line growth.